Physician profile
Vaughn E Whittaker
NPI 1982866513
$2,726.84
in general payments reported to CMS, 2019-2025
12 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $253 · 2022: $175 · 2023: $922 · 2024: $1,134 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,768 · Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,768.21 |
| Food and Beverage | $407.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $921.80 | 2023 | Organ Care System |
| Intuitive Surgical, INC. | $846.41 | 2024 | |
| Veloxis Pharmaceuticals, INC. | $414.86 | 2020-2022 | |
| Polynovo North America LLC | $273.46 | 2024 | Novosorb Btm |
| Medline Industries LP | $124.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $91.71 | 2025 | Nulojix |
| Angiodynamics, INC. | $27.63 | 2025 | Nanoknife |
| Becton, Dickinson and Company | $14.21 | 2024 | Phasix Mesh |
| Lemaitre Vascular, INC. | $12.45 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaughn Whittaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.